Quality Of Life In Colorectal Cancer Survivors
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorInstitute of Oncology Ljubljana
About this trial
The purpose of this study is to identify late adverse effects in colorectal cancer patients that may influence quality of life at 6, 12, and 24 months after oncological treatment. The study aims to assess quality of life in colorectal cancer survivors in relation to psycho-physical-social well-being at different time points and to evaluate the prevalence of late adverse effects and their association with diagnosis and specific oncological treatment.
Eligibility criteria
Qualifiers
Patients with colorectal cancer (colon or rectal cancer)
Age 25 to 65 years
First oncological treatment performed at the Institute of Oncology Ljubljana
Working-capable patients
Disqualifiers
Age < 25 years or > 65 years
Patients unable to complete questionnaires
Patients unable to participate in follow-up assessments
Patients who do not provide written informed consent
Trial design
Treatments tested in this trial
- Quality of Life Assessment
Treatment groups
368 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov